G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 719,985 | $31,291,000 | 2.32% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 72,000 | $3,121,000 | 1.20% |
EMERALD ADVISERS, LLC | 506,424 | $22,009,000 | 0.83% |
Virtus ETF Advisers LLC | 18,103 | $787,000 | 0.70% |
Birchview Capital, LP | 22,000 | $956,000 | 0.65% |
EMERALD MUTUAL FUND ADVISERS TRUST | 352,053 | $15,300,000 | 0.55% |
Hillhouse Capital Management | 699,431 | $30,397,000 | 0.52% |
Rock Springs Capital Management LP | 300,000 | $13,038,000 | 0.50% |
BB BIOTECH AG | 352,607 | $15,324,000 | 0.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 287,000 | $12,473,000 | 0.44% |